Barr settles antitrust lawsuit over Ovcon for $5.9M

Generic-drug maker Barr Pharmaceuticals will pay $5.9 million to end an antitrust lawsuit filed by 34 states over claims that it received $20 million to hold off on marketing its version of Warner Chilcott Ltd.'s Ovcon, an oral contraceptive. Under the terms of the settlement, Barr is prohibited from entering into noncompetition agreements with firms that market brand name treatments for the next decade. A spokeswoman for Barr denied any wrongdoing, saying that the company still deems the deal with Warner Chilcott "legal, legitimate and pro-competitive."

View Full Article in:

California Chronicle (Los Angeles) · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD